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Abstract 
Amyloid β-peptide (Aβ) is a major component of plaques in Alzheimer’s disease, and 
formation of senile plaques has been suggested to originate from regions of neuronal 
membrane rich in gangliosides. We analyzed the mode of interaction of Aβ with lipid 
bilayers by multinuclear NMR using 31P nuclei. We found that Aβ (1-40) strongly 
perturbed the bilayer structure of dimyristoylphosphatidylcholine (DMPC), to form a 
non-lamellar phase (most likely micellar). The ganglioside GM1 potentiated the effect of 
Aβ (1-40), as viewed from 31P NMR. The difference of the isotropic peak intensity 
between DMPC/Aβ and DMPC/GM1/Aβ suggests a specific interaction between Aβ and 
GM1. We show that in the DMPC/GM1/Aβ system there are three lipid phases, namely a 
lamellar phase, a hexagonal phase and non-oriented lipids. The latter two phases are 
induced by the presence of the Aβ peptide, and facilitated by GM1. 
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1. Introduction 
 Alzheimer’s disease (AD) is a devastating neurodegenerative disease affecting up 
to 15 million individuals worldwide. The brains of Alzheimer’s disease patients are 
characterized by fibrillar amyloid plaques that are associated with progressive deposits 
(Iversen et al., 1995). The principal component of amyloid deposits is a 39-42 amino acid 
residue peptide, Aβ (Glenner et al., 1984; Masters et al., 1985), a product of proteolytic 
processing of a much larger amyloid precursor protein encoded by a gene on 
chromosome 21 (Kang et al., 1987). Several spectroscopic investigations have clarified 
the structure of the fibrils, which form a ‘cross-β sheet’ structure (Kirschner et al., 1986; 
Petkova et al., 2002; Petkova et al., 2006). Moreover, a link between Aβ and AD 
neuropathological lesions is demonstrated by the toxicity of aggregated Aβ to neuronal 
cells in culture (Lambert et al., 1998) and in aged brain (Geula et al., 1998). However, the 
molecular mechanisms of the neurotoxic action of Aβ remain unknown.  A growing 
number of observations indicate that Aβ may alter the physicochemical properties of 
neuronal membranes, including membrane fluidity (Muller et al., 1995) and permeability 
to ions and nonelectrolytes (Arispe et al., 1993; de Planque et al., 2007; Lau et al., 2006). 
These findings strongly suggest that at least some of the pathophysiological effects of Aβ 
may be mediated by Aβ-membrane interactions. Indeed, a number of studies have shown 
that Aβ is able to perturb lipid bilayers (Arispe et al., 1993). Interest in studies of the 
interaction between Aβ and constituents of brain membranes has been further stimulated 
by the identification of an Aβ-GM1 ganglioside-bound form in AD brain (Chi et al., 
2007; Kakio et al., 2002; Yanagisawa et al., 1995). 
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 Gangliosides (Brocca et al., 1997; Kasahara et al., 2001) are sialic acid-containing 
glycosphingolipids and consist of two main components: a hydrophobic ceramide unit, 
which anchors the ganglioside to the plasma membrane, and a hydrophilic 
oligosaccharide chain, to which one or more sialic acid groups are attached. Gangliosides 
are abundant components of neuronal membranes and are involved in important 
neurobiological events such as neurodifferentiation, synaptogenesis, and synaptic 
transmission (Nagai, 1995). Aβ permeabilizes ganglioside-containing membranes and 
thus disturbs ion homeostasis (McLaurin et al., 1996; McLaurin et al., 1998a). Different 
research groups have reported extensive studies of Aβ-ganglioside interactions 
investigated by different methodologies (Choo-Smith et al., 1997; Kakio et al., 2003; 
Kakio et al., 2002; McLaurin et al., 1996; McLaurin et al., 1998b; Yanagisawa et al., 
1998), but no conclusive results have been obtained. GM1 ganglioside-mediated 
accumulation of Aβ protein was proposed together with an effect of cholesterol (Kakio et 
al., 2003). Recently, we have demonstrated using solution state NMR on 15N-labelled Aβ 
(1–40) and Aβ (1–42) that the interaction with ganglioside GM1 micelles is localized to 
the N-terminal region of the peptide, particularly residues His13 to Leu17, which become 
more helical when bound, leaving the C-terminal region unstructured (Williamson et al., 
2006). Further, insertion of Aβ peptide into lipid bilayer to cause micellar structure was 
proposed on the basis of a monolayer study (Bokvist et al., 2004; Brender et al., 2007; 
Chi et al., 2007). These studies imply that the main driving force for interaction is not 
coulombic, in accordance with the low net charge on the Aβ peptide. 
      In this paper, we have recorded 1H decoupled 31P solid-state NMR spectra of the 
neutral lipid dimyristoylphosphatidylcholine (DMPC) and DMPC/GM1 ganglioside in a 
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mechanically oriented system in the presence of Aβ(1-40) in order to clarify the behavior 
of Aβ in the presence of GM1 ganglioside. DMPC is a commonly used model lipid for 
neutral membranes. 2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine (POPC) is also 
frequently used, and is very similar except that the phase transition temperature of the 
former is higher than that of the latter. 
     We also recorded 13C NMR spectra of 13C-labeled Aβ (1–40) incorporated into liquid 
crystalline DMPC bilayer, to gain insight into conformational features of this peptide.  
 
2. Results 
First, we recorded the orientational behavior of DMPC lipid bilayers as a function 
of Aβ peptide using angular-dependent solid-state 31P NMR experiments. The 31P 
chemical shift tensors of phospholipids are represented graphically by an ellipsoid. The 
three main axes of the ellipsoid represent the main tensor elements δ11 ≥ δ22 ≥ δ33. The 
chemical shift that is measured at a certain orientation of the molecule corresponds to the 
length of a vector parallel to the magnetic field direction, and the dependence of shift on 
orientation (ie the chemical shift anisotropy, CSA, given by Δ = δ// - δ⊥) is highly 
sensitive to electrostatic interactions and dynamics near the lipid surface (Ramamoorthy 
et al., 2006b; Santos et al., 2004). Thus the chemical shifts indicate the tilt of the 
phospholipids with respect to the magnetic field and/or the mobility of the lipid bilayers. 
In the case of a completely oriented lipid bilayer, 31P NMR peaks obtained with aligned 
samples are narrow and there is only a small powder resonance under the aligned signal. 
In a first set of experiments, we observed 31P solid-state NMR spectra of powder 
and glass-plate aligned DMPC samples as shown in Fig. 1. These results indicate that the 
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DMPC lipid bilayer was completely oriented on the glass plates. The 31P chemical shift 
values of DMPC move to high field on changing the alignment axis to the magnetic field 
B0 from 0° to 90°.  Fig. 1(d) and (e) show angular-dependent 31P NMR spectra of a 
DMPC/GM1 ganglioside system. The behavior of this system is similar to the result in a 
DMPC lipid bilayer alone, implying that the addition of GM1 ganglioside does not 
significantly perturb the structure of the DMPC bilayer.  
 Fig. 2 illustrates the 31P NMR spectra of a mechanically oriented DMPC bilayer 
as a function of the angle (θ) between the applied magnetic field and bilayer normal. The 
left, central and right traces correspond to the 31P NMR spectra of DMPC/Aβ(1-40) 
molar ratios of 30:1, 20:1 and 10:1, respectively. Four peaks can be distinguished whose 
positions vary with the angle, while an isotropic peak remains almost at the same position 
independent of orientation angle. In particular, the outermost pairs among the four peaks 
exhibit an orientation-dependent displacement of peaks. In addition, the separation of the 
outer and inner peaks varies with orientation, corresponding to the CSAs of the 
phosphodiester moieties, as summarized in Table 1. The anisotropy values of the outer 
and inner pairs decrease from 43.4 and 30.9 ppm, respectively, at a low proportion of Aβ 
(1-40) to 38.0 and 22.9 ppm at a higher ratio (Table 1), suggesting that the alignment of 
the DMPC bilayers is reduced in the presence of Aβ peptide. The most anisotropic 
component (ie, most ordered) is attributed to a lamellar bilayer, in agreement with the 
observed CSA values. The component with reduced anisotropy is assigned to a different 
and therefore non-lamellar structure, most likely the hexagonal HII form (Cullis et al., 
1979) based on its orientation dependence and the fact that the observed CSA value is 
approximately half the value measured for the bilayer structure (Smith et al., 1984; 
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Thayer et al., 1981). The same structure was recently proposed to be induced by 
antimicrobial peptides (Ramamoorthy et al., 2006a). The isotropic peak is assigned to a 
disordered component showing rapid isotropic averaging. The most likely origin of this 
peak is from micellar components. We note that the chemical shift of the ‘isotropic’ 
signal varies with alignment. This is not inconsistent with micellar structure, because 
micelle chemical shifts will still show orientation dependence because of differences in 
bulk magnetic susceptibility.  
Most significantly, the anisotropies of the ordered components are reduced with 
increased proportion of Aβ (1-40) (Fig 2, (a) to (b) to (c)). This observation is consistent 
with insertion of Aβ (1-40) into the membrane, because the observed anisotropies are 
averages of the large anisotropy arising from free lipids and the smaller anisotropy 
arising from lipids in direct contact with the peptide.  
Next, we measured the 31P angular-dependent NMR spectra of a range of DMPC/ 
GM1 ganglioside systems in the presence of Aβ (1-40), as shown in Fig. 3. No 
orientational distribution for DMPC molecules was observed at a DMPC/GM1 
ganglioside ratio of 5:1 (data not shown).  Therefore, we decided to perform an 
experiment using a ratio of DMPC to GM1 ganglioside of 10:1. In this case, it is notable 
that the relative intensity of the isotropic peak was substantially increased. With 
increasing concentration of Aβ (1-40) peptide, the intensity of the isotropic signal 
gradually increased further. This result indicates that the lipid bilayer was gradually 
disrupted with increasing Aβ (1-40) peptide concentration, again highly suggestive of 
insertion of Aβ into the membrane.  The fraction of the lamellar structure of DMPC was 
decreased with respect to that of DMPC without Aβ (1-40) peptide. A similar decrease in 
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the proportion of oriented phospholipids on glass plates has also been reported in the 
presence of other membrane-bound peptides (Moll et al., 1990; Nicholson et al., 1987). 
As expected, the chemical shifts of the two oriented components are dependent on their 
angle relative to the magnetic field. In the case of the DMPC/GM1/Aβ system, the 
oriented components make up only about 60% of the observed DMPC signal.  It appears 
that the fraction of isotropic component in DMPC/ Aβ (1-40) peptide samples depends on 
the amount of Aβ (1-40) peptide present. However, the proportion of the isotropic lipids 
is almost independent of lipid/peptide ratio when GM1 is present, as shown in Fig. 4.  
We recorded 13C NMR spectra of 13C labeled Aβ (1-40) incorporated into liquid 
crystalline DMPC bilayers by DD- and CP-MAS methods, as shown in Figs 5A and 5B, 
respectively, in order to gain insight into conformational features of the peptide. In DD-
MAS, mobile regions of the sample are more intense, whereas in CP-MAS, mobile 
regions are much less intense. 13C NMR signals could not be detected for [2-13C]G29 
because of low S/N ratios. Local peptide conformations can be readily characterized by 
their 13C chemical shifts with reference to the corresponding conformation-dependent 
chemical shifts (Saito, 1986), permitting assignment of Val18 C=O signals from α-helical 
and β-sheet conformations. The intensities of these signals differ substantially between 
the DD-MAS and CP-MAS NMR methods. We conclude that the α-helical peptide 
conformation is significantly flexible and is approximately equally partitioned between 
components penetrated into lipid bilayer and in liquid phase, whereas the β-sheet peptide 
conformation is rigid and is presumably deposited and stacked at the bilayer surface. 
Indeed, the latter peak alone can be detected by 13C CP-MAS NMR (Fig. 5B). 
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3. Discussion 
 We have shown in this paper that the bilayer structure is strongly perturbed by the 
presence of Aβ (1-40) peptide and also GM1, leading to a fraction of anisotropic but non-
lamellar structure suggested to be the hexagonal HII structure. At the same time, the 
proportion of an isotropic lipid phase such as micelle or single vesicle increases, as 
determined from 31P NMR spectra. Such perturbation to the bilayer was significantly 
more prominent when GM1 was present. The assignment of the non-lamellar phases to 
HII and micellar structures is based partly on the observation that lipid polymorphic 
structure is strongly related to the shape of lipids: a cylindrical lipid such as 
phosphatidylcholine favors bilayer structure, while cone-like lipids such as (unsaturated) 
phosphatidylethanolamine, cardiolipin and phosphatidic acid-Ca2+ prefer to take a 
hexagonal HII form (Cullis et al., 1979). Further, an inverted cone such as GM1 favors a 
micellar structure. 
     Non-lamellar lipid structures, such as that revealed here by 31P NMR, have been 
reported for a number of biological membranes and reconstituted P-450 systems (De 
Kruijff et al., 1978; Stier et al., 1978). Several peptides including gramicidin, alamethicin, 
α-helical peptide and antimicrobial peptide also were shown to perturb bilayer structure 
to form non-lamellar hexagonal HII lipids by peptide-induced changes in lipid phases 
(Cornell et al., 1988; Gasset et al., 1988; Keller et al., 1996; Killian et al., 1985), in 
addition to the effect of lipid molecules themselves as mentioned above. The 
hydrophobicity and conformational flexibility of transmembrane peptides in lipid bilayers 
can affect their propensity to induce the formation of inverted non-lamellar phases by 
mechanisms not primarily dependent on lipid-peptide hydrophobic mismatch (Liu et al., 
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2001), although we note that a theoretical interpretation of a mechanism of the lamellar-
to-inverted hexagonal phase transition was also proposed, in relation to the membrane 
fusion process (Siegel, 1986; Siegel et al., 1997). For this reason, it is likely that the 
effect of Aβ (1-40) arises from interaction with the lipid bilayer, following an initial 
penetration into the bilayer. The effect of ganglioside, however, on modulation of 
lamellar-inverted micelle (HII) phase transition has been examined in relation to 
biomembranes and shown to vary depending upon the relative concentration of 
ganglioside to lipids (Siegel, 1986). 
As pointed out already, this possibility was proved by the conformational study of 
the peptide by 13C NMR spectra as shown in Fig. 5, which demonstrates that not all the 
Aβ (1-40) peptides necessarily interact with lipid molecules, because there remains a 
fraction of the Aβ population deposited upon the bilayer surface as a rigid β-sheet 
structure, although the relative proportion may be varied by several parameters such as 
peptide-lipid ratio, degree of hydration, temperature, etc.  
 The results described here show that Aβ (1-40) is capable of inserting into lipid 
membranes, and eventually disrupting the membrane structure, which is enhanced by the 
presence of GM1. It has previously been shown that Aβ (1-42) causes leaky peptide-lipid 
supramolecular structures, as a result of its membrane disrupting effect (Ambroggio et al., 
2005). Indeed, the aggregation propensity of Aβ (1-42) was shown to be higher than that 
of Aβ (1-40) (Bateman et al., 2007). Consequently, it was demonstrated that the former 
peptide disrupts the membrane bilayer. Nevertheless, it is emphasized that the very long 
timescale for development of Alzheimer’s disease supports the argument that any 
interaction that is thermodynamically feasible will eventually occur, and therefore that 
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insertion of Aβ into the membrane as an α-helical form and subsequent membrane 
disruption may be physiologically relevant. By contrast, the β-sheet peptides on the 
membrane surface are rigid (as seen from the 13C data) and are therefore probably not 
interacting strongly with the lipid, and thus not involved in promotion of either micellar 
nor isotropic phase formation. 
 
4. Materials and Methods 
4.1 Materials 
 DMPC and GM1 ganglioside were purchased from Sigma (St. Louis, MO, USA). 
Unlabeled and 13C labeled Aβ(1-40) 
(DAEFRHDSGY10EVHHQKLVFF20AEDVGSNKGA30IIGLMVGGVV40 and  
DAEFRHDSGYEVHHQKL[1-13C]V18FF[3-13C]A21EDVGSNK[2-
13C]G29AIIGLMVGGVV) were synthesized in a stepwise fashion on Fmoc-Val-PEG-PS 
resin (PE Biosystems) by a PioneerTM peptide synthesizer (PE Biosystems) using Fmoc 
amino-acids, including 13C labeled ones. After synthesis, the peptides were cleaved from 
the resin by treatment with a mixture of TFA, phenol, triisopropylsilane and water 
(88:5:2:5 vol%) for 2 hours at room temperature. The precipitated peptide was washed 
repeatedly with cold diethylether. Then, the crude peptide was purified by preparative 
liquid chromatography. Peptides were > 95% pure by chromatography. 
 For the preparation of oriented samples, various ratios of DMPC/Aβ mixtures 
were prepared; for DMPC/Aβ (10:1), 7.0mg (8.6 μmol) of DMPC was dissolved in 100 
μl of methanol/chloroform (1:1) solution and 3.7mg of Aβ peptide (0.85 μmol) was 
dissolved in 300 μl of benzene.  Then, these solutions were mixed and spread onto 0.1 
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mm thick glass plates (5×9 mm), followed by complete drying under vacuum for 24 h.  
The dry plates thus prepared were stacked in a 10 φ NMR tube (20 mm length), together 
with ultra-pure water in order to achieve 60% (w/w) hydration (6.4 μl of water in Aβ 
peptide/DMPC(1:10)). Then, the sample tubes were sealed with a Teflon cap and epoxy 
resin, and incubated at 45 °C for 4 days.  The DMPC/GM1/Aβ peptide systems were 
prepared by a method similar to that described above. The molar ratios of these samples 
were achieved to satisfy the following conditions:   
DMPC:Aβ=10:1, 20:1, 30:1 (molar ratio),  
DMPC:GM1:Aβ=10:1:0.5, 10:1:1, 10:1:1.5 (molar ratio) 
 Multilamellar vesicles were prepared by dissolving DMPC in 
methanol/chloroform (1:1) and Aβ peptide in benzene solution as described previously 
(peptide: lipid= 1:10 molar ratio). The solvents in the DMPC /Aβ peptide samples were 
removed by nitrogen gas, followed by pumping under vacuum until the lipid film was 
completely dry. The dried lipid thus obtained was suspended in 65.6 μl of ultra-pure 
water in order to achieve 80%(w/w) hydration. and homogenized by six cycles of 
successive freezing, thawing and vortexing for 5 min each and freezing. Then, the sample 
was incubated at 35 ºC for 24 h.  
 
4.2 NMR measurements 
 High power proton-decoupled 31P NMR spectra at ambient temperature were 
performed on a Chemagnetics CMX 400 spectrometer operating at a resonance frequency 
of 397.79 MHz for 1H and 161.03 MHz for 31P. A static double-resonance probe 
equipped with a goniometer was used. 31P NMR spectra were recorded for the oriented 
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samples. For the 31P NMR experiments, typical NMR parameters were 7~8μs (90°) pulse 
length, 3 s recycle delay and the number of transients ranged from 1000 to 2000. The 31P 
chemical shifts in ppm were referenced to H3PO4.  A Gaussian line broadening of 200 Hz 
was applied to all static 31P NMR spectra. 
High resolution 13C NMR spectra of unoriented 13C labeled Aβ (1-40) incorporated 
into fully hydrated DMPC bilayer of liquid crystalline phase were recorded on a 
Chemagnetics CMX-400 NMR spectrometer, using 13C CP/MAS NMR and dipolar 
decoupled magic angle spinning (DD/MAS) with a single pulse excitation method, at 
38°C. The π/2 pulse for carbon and proton nuclei was 5 μs and a 1H decoupling 
frequency of 60 kHz was used. Free induction decays were usually acquired with 512 
data points, using a 3 s recycle delay and 2 ms contact time. The number of transients for 
the 13C CP/MAS and 13C DD/MAS spectra are 16,000 and 60,000, respectively.  13C 
chemical shifts were referred to adamantane [(28.8ppm from tetramethylsilane (TMS)] 
and then expressed as relative shifts from the value of TMS. A Gaussian line broadening 
of 40 Hz was applied to CP/MAS and DD/MAS NMR spectra. 
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Table 1  Chemical shift difference between the parallel and perpendicular components of the 
31P shift of DMPC lipid bilayer in the presence of Aβ (1-40).  
 
 
 
 2
Figure legends 
Fig. 1  1D 31P 1H-decoupled solid-state NMR spectra of non-oriented and oriented DMPC 
samples at 35°C. θ is the angle between the bilayer normal and B0 (see insert). (a) 
non-oriented DMPC sample. The dotted line is the spectral simulation, which gives the 
following average chemical shift anisotropy (CSA) principal values for 31P of DMPC: 
σ11 = -16 ppm, σ22 = -16 ppm, σ33 = 31 ppm and σiso = -1 ppm. (b) Oriented DMPC 
bilayer sample with the order axis parallel to the magnetic field. (c) Oriented DMPC 
bilayer sample with the order axis perpendicular to the magnetic field. (d) and (e) 
Oriented bilayers of DMPC:GM1-ganglioside in molar ratio 10:1, with the order axis 
respectively parallel and perpendicular to the magnetic field.  
 
Fig. 2 31P solid state NMR spectra of macroscopically oriented DMPC samples incorporating 
varying ratios of Aβ (1-40) at 35ºC as a function of the angle between the bilayer and 
the magnetic field. DMPC/Aβ (1-40) molar ratios were (a) 30:1, (b) 20:1, (c)10:1 
respectively.  θ is the angle between the bilayer normal and B0. The dashed lines 
indicate the positions of the outer (long dashes) and inner (short dashes) lines at 0 and 
90°: from their intensities these are identified as the parallel and perpendicular 
components respectively. The asterisks identify the isotropic component.  
 
 3
Fig. 3 31P solid state NMR spectra of macroscopically oriented DMPC/GM1 samples 
incorporating varying ratios of Aβ (1-40) at 35ºC as a function of the angle between the 
bilayer and the magnetic field. DMPC/GM1/Aβ (1-40) molar ratios were (a) 10:1:0.5 
(b) 10:1:1 (c) 10:1:1.5 respectively.  θ is the angle between the bilayer normal and B0. 
The asterisks identify the isotropic component. 
 
Fig. 4 Changes of isotropic signal fraction of DMPC/Aβ and DMPC/GM1/Aβ as a function of 
lipid/Aβ ratio. Triangles are DMPC/Aβ and squares are DMPC/GM1/Aβ. The error in 
the isotropic fraction is approximately 5%. 
 
Fig. 5  13C DD-MAS(a) and CP-MAS NMR(b) spectra of 13C-labeled Aβ (1-40) 
[DAEFRHDSGYEVHHQKL[1-13C]V18FF[3-13C]A21EDVGSNK[2-13C]G29AIIGLMV
GGVV] incorporated into liquid crystalline DMPC bilayer. 13C NMR signals of Gly29 
Cα were of too low signal-to-noise ratio to be useful. Comparison with spectra of pure 
lipid shows that the signal at approximately 171.3 ppm is from the lipid carbonyl 
groups. 
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